When most people hear the word collagen, they think of skin, joints, bones and connective tissue.
And for good reason.
Collagen is the body's most abundant protein and provides structural support throughout the body. But research into collagen peptides is beginning to reveal another side of collagen biology.
Some collagen peptides appear to interact with biological processes involved in digestion and metabolic regulation.
This has opened an intriguing new area of research: metabolic collagen.
At the centre of this research is a specific collagen peptide preparation called Nextida® GC.
Unlike conventional collagen research, which has largely focused on tissues such as skin, cartilage and connective tissue, researchers investigating Nextida® GC are examining what happens after collagen peptides are consumed before a meal.
The findings are beginning to show that particular collagen peptides can influence the body's natural response to food.
What is metabolic collagen?
The term metabolic collagen describes an emerging area of collagen research focused on how specific collagen peptides may interact with processes involved in metabolic regulation.
The important word is specific.
Hydrolysed collagen is made by breaking collagen down into smaller peptides. The resulting peptide profile depends on the source of collagen and the way it is processed.
Researchers have found that different collagen hydrolysates can therefore have different biological properties.
This became particularly interesting when researchers began screening collagen hydrolysates for their effects on GLP-1, an important hormone released by the digestive system after eating.
GLP-1 is part of the body's natural system for coordinating food intake, digestion, insulin secretion and blood glucose regulation.
The question was simple:
Could particular collagen peptides influence this natural response?
Research into Nextida® GC suggests that they can.
From collagen peptides to GLP-1
The story began with laboratory research comparing different collagen hydrolysates.
Researchers screened specific collagen peptide preparations for their ability to stimulate GLP-1 release.
One preparation stood out.
It was identified as H80 in the original research and subsequently became known as Nextida® GC.
Further laboratory and animal research found that this specific collagen hydrolysate was associated with increased GLP-1 release and changes in glucose tolerance and gastric emptying.
The researchers then moved into human studies.
That progression is important because it follows the way nutritional science should develop:
Identify a biological signal → investigate the mechanism → study the response in humans.
The first human findings were published in 2024.
The first human study
The 2024 study investigated the effect of the specific collagen hydrolysate in people with normal glucose regulation and people with prediabetes.
Participants consumed the collagen preparation before a standardised meal, allowing researchers to examine what happened to their blood glucose and hormone responses.
The researchers observed a reduction in the post-meal glucose response.
The study also provided evidence of an increase in GLP-1 following consumption of the specific collagen peptides.
These findings provided the first human evidence that a particular collagen peptide preparation could influence the body's response to a meal.
But this was only the beginning.
The next question was more detailed:
What exactly was happening inside the body?
The 2026 human study
Published research in 2026 has now taken the investigation considerably further.
The study was a randomised, double-blind, placebo-controlled crossover trial involving 30 adults.
Twelve participants had normal glucose regulation and 18 had prediabetes.
Participants consumed 10 g of the specific collagen peptide preparation 30 minutes before a standardised carbohydrate-rich meal.
Researchers then measured a range of physiological responses, including:
- Blood glucose
- GLP-1
- GIP
- Insulin
- C-peptide
- Gastric transit
This allowed the researchers to look at the response as a biological sequence rather than focusing on a single measurement.
And the results were particularly interesting.
A different response to the meal
Following consumption of the collagen peptides, researchers observed a significantly lower postprandial glucose response compared with placebo.
The overall glucose exposure following the meal was reduced, with the difference in glucose iAUC reaching statistical significance.
This is important because post-meal glucose regulation is not simply about what happens to blood glucose at one particular moment.
It is about how the body manages the rise in glucose after food enters the digestive system.
The research suggests that specific collagen peptides can influence that response.
GLP-1 rose before the meal
One of the most striking findings occurred before participants had even eaten.
During the 30-minute period between consuming the collagen peptides and eating the meal, researchers observed significantly higher concentrations of GLP-1 compared with placebo.
The increase was statistically significant at P < 0.0001.
The researchers also observed a significant increase in GIP, another incretin hormone involved in the body's response to nutrients.
Again, the increase occurred during the pre-meal period.
This gives us an important insight into the sequence of events.
The collagen peptides were consumed first.
The incretin response followed.
The meal came afterwards.
The body's metabolic response to that meal then occurred in the context of those earlier hormonal changes.
Why GLP-1 matters
GLP-1 is one of the body's naturally occurring incretin hormones.
It is released by the digestive system in response to nutrients and helps coordinate several processes involved in the handling of food.
Among its physiological roles are:
- Supporting glucose-dependent insulin secretion
- Influencing gastric emptying
- Contributing to appetite regulation
- Helping coordinate the body's response to nutrients
This makes GLP-1 particularly interesting in the context of metabolic health.
The significance of the Nextida® GC research is that the collagen peptides were associated with an increase in the body's own GLP-1 response.
The research therefore points towards an interaction between specific collagen peptides and the body's natural nutrient-sensing system.
The insulin response tells another part of the story
The 2026 researchers also measured insulin and C-peptide to understand how the pancreatic response changed.
An early increase in insulin was observed during the collagen peptide preload period.
Across the broader measurement period, however, total insulin exposure was not significantly different from placebo.
This gives the research a more detailed physiological picture.
The collagen peptide preload was associated with an earlier hormonal response, followed by a different glucose response to the meal.
Rather than simply looking at whether insulin went up or down, the researchers were able to examine when the response occurred and how it related to the subsequent meal.
That timing is an important part of the biology.
Gastric transit provides another piece of the puzzle
The researchers also investigated what was happening inside the digestive system.
In participants with prediabetes, the collagen peptide preparation significantly increased gastric residence time.
The reported difference was approximately 37 minutes.
This matters because gastric emptying is an important part of post-meal physiology.
The stomach does not simply act as a storage container. The rate at which its contents move into the small intestine influences how nutrients are delivered for digestion and absorption.
The 2026 findings therefore add another dimension to the research.
The specific collagen peptides were associated with changes in:
Incretin hormones → gastric transit → post-meal glucose regulation
These processes are biologically connected, making the findings particularly interesting.
Why the peptide matters
One of the most important lessons from this research is that the word collagen does not tell the whole story.
Collagen peptides are not necessarily interchangeable.
The biological properties of a collagen hydrolysate can depend on its peptide composition.
This is why the research programme behind Nextida® GC is so interesting.
Researchers did not simply take a conventional collagen product and test whether it affected weight.
They began by investigating whether different collagen peptide preparations had different biological effects.
They then identified a particular preparation with an interesting effect on GLP-1.
That preparation was investigated further through preclinical research and human studies.
The result is a much more targeted approach to collagen nutrition.
The question is no longer simply, “Does collagen work?”
It becomes:
Which collagen peptides?
For which biological process?
At what dose?
When should they be consumed?
And what does the human evidence show?
That is where the next generation of collagen research becomes particularly interesting.
From post-meal glucose to weight management
The connection to weight management begins with biology.
The body's regulation of appetite, digestion, gastric emptying, insulin and blood glucose is interconnected.
GLP-1 sits within that system and is involved in several of these processes.
The 2026 research adds evidence that a specific collagen peptide preparation can influence GLP-1 and GIP responses, gastric residence and post-meal glucose regulation.
This creates an interesting nutritional pathway for further investigation.
Instead of approaching weight management simply through calorie restriction, researchers are increasingly interested in the biological systems that help regulate how the body responds to food.
That includes the signals produced by the digestive system itself.
And this is where metabolic collagen represents a genuinely interesting development in nutritional science.
Why timing matters
The 2026 study also highlights another important concept: when an ingredient is consumed can matter.
Participants consumed the collagen peptides 30 minutes before the meal.
The early GLP-1 and GIP response occurred during that preload period.
This means the research is not simply about adding collagen to the diet.
It is investigating a specific peptide preparation consumed at a specific dose and at a specific point in relation to food.
That level of precision is characteristic of the emerging field of purpose-built nutritional formulations.
The evolution of collagen research
Collagen research has come a long way.
Early interest centred largely on collagen as a structural protein.
Then researchers began investigating hydrolysed collagen peptides and their absorption.
Clinical research subsequently explored applications involving skin, joints, connective tissue, muscle and other aspects of health.
Now researchers are investigating whether specific collagen peptides can interact with metabolic signalling pathways.
Nextida® GC sits within this newer generation of research.
The journey from laboratory screening to human research is particularly interesting because it demonstrates how a nutritional ingredient can be investigated according to its biological activity rather than simply according to its nutritional composition.
That is a very different way of thinking about collagen.
Where Slimsafe® fits
Slimsafe® was developed around this emerging area of metabolic collagen research.
Its purpose-built formulation includes Nextida® GC, the specific collagen peptide preparation investigated in the human research described above.
The formulation reflects a simple CollagenX principle:
Understand the biology. Review the evidence. Formulate with purpose.
The product is Slimsafe®.
The ingredient is Nextida® GC.
The biological territory is appetite and metabolic support.
Keeping those distinctions clear is important because it allows the science to remain the starting point.
Slimsafe® isn't built simply because collagen is popular.
It was developed around a specific biological question:
Can carefully selected collagen peptides support the body's natural systems involved in appetite and metabolic regulation?
The emerging human evidence makes that question increasingly interesting.
A new direction for collagen
The most exciting thing about metabolic collagen may not be the idea that collagen could have another use.
It is what the research tells us about collagen itself.
Collagen peptides can be studied as biologically active nutritional ingredients with properties that depend on their specific peptide composition.
That opens the door to a more precise approach to nutritional formulation.
Instead of asking how many ingredients can be put into a product, researchers can begin with a biological process and ask:
What does the body naturally do?
Where could nutritional support be relevant?
Which ingredients have evidence for that biological process?
And how should they be formulated?
That is the direction in which collagen research is moving.
From collagen as a generic protein source to specific peptides investigated for specific biological purposes.
The 2024 and 2026 human research into Nextida® GC provides an intriguing example of this transition.
And it may be one of the first steps towards a much broader understanding of what carefully selected collagen peptides can do.
The research
Grasset E, Briand F, Virgilio N, et al. A Specific Collagen Hydrolysate Improves Postprandial Glucose Tolerance in Normoglycemic and Prediabetic Mice and in a First Proof of Concept Study in Healthy, Normoglycemic and Prediabetic Humans. Food Science & Nutrition. 2024;12(11):9607–9620.
Virgilio N, Schön C, Steiner N, et al. Specific Collagen Peptides Support Postprandial Metabolic Health by Modulating Incretin Hormones, Gastric Transit, and Glycemic Control in Participants with Normoglycemia and Prediabetes. Current Developments in Nutrition. 2026.
